News & events
News
Stefan Bröer is looking for the right molecule for a biological target, that could be developed into a drug to treat diabetes. Now ANU has its own library of compounds, available to biological and medical researchers, managed by the Research School of Chemistry.
Aude Fahrer's work aims to activate the immune cells responsible for attacking cancer, in a simple, low cost way.
Alex Maier has been elected as a Fellow of the Australian Society for Parasitology.
They say leaders are born not made, but it seems the opposite is true for queen bees, according to a new study by researchers from The Australian National University (ANU) and Queen Mary University of London.
New research from The Australian National University (ANU) has drilled down to the molecular level to find similarities across six pharmaceutical drugs used in pain relief, dentist anaesthetic, and treatment of epilepsy, in a bid to find a way to reduce unwanted side-effects.
Linden Muellner-Wong has won a 2017 RSB Director's Prize in Honours.
Events
Toxoplasma gondii belongs to the apicomplexan phylum, a group of medically and economically important parasites worldwide. T. gondii causes toxoplasmosis which can result in severe disease in immunocompromised people, neonates, and livestock.
Malaria is a mosquito-borne infectious disease, with its most severe form caused by the protozoan parasite Plasmodium falciparum. The rapid emergence and spread of drug‑resistant parasites demand new therapeutic strategies.
My PhD work defines the sources and mechanisms of cholesterol uptake in P. falciparum-infected RBCs and demonstrates how this pathway can be exploited to improve antimalarial drug delivery and therapeutic index.
In this talk, I will show how combining phylogenetic inference, protein structure prediction, and ancestral sequence reconstruction opens new ways to investigate how protein functions originate and diversify across the tree of life.
Just as the development of the first light microscopes uncovered a new microbial frontier, the use of high-throughput sequencing and metagenomics has uncovered a new frontier of unculturable microorganisms, often referred to as “microbial dark matter”.
Matthew's laboratory focuses on the incredibly multifunctional Omp85 protein superfamily which conduct essential processes in the outer membranes of all Gram-negative bacteria such as protein folding, insertion, and translocation reactions, as well as lipid transport reactions.